Par Pharmaceutical Companies
Par Pharmaceutical Companies: quarterly report (amended) for the quarter ended Jun 30, 2011
- Form
- 10-Q/A
- Filed
- Period
- Importance
- Routine
- Accession
- 0000878088-11-000077
- Document
- 10-Q/A
- Exhibit 10.2
- Share purchase agreement
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
